This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Beatriz Llamusi, PhD
Chief Executive Officer & Co Founder at Arthex Biotech
Speaker

Profile

MSc and Ph.D. in Biochemistry at the University Miguel Hernández. During her Ph.D., she focused on the molecular bases of neuronal regeneration. After that, she started working in the Department of Genetics as a postdoctoral researcher. She dedicated more than 13 years to investigate the pathogenesis mechanisms and therapeutic approaches in rare neuromuscular diseases. During this period, she produced 29 scientific articles and seven related patents. In addition, she was PI in 5 competitive projects and supervised 4 Ph.D. projects. During the initial steps of the project that led to Arthex foundation, she was granted different competitive acceleration programs (FIPS and Caixaimpulse) to assess the feasibility of the entrepreneurial project, including training in business management and development, IPP, financial and regulatory issues. She co-founded ARTHEx Biotech in December 2019 and has been CEO since then.

Agenda Sessions

  • Use of a Lipophilic-conjugation to Deliver Antimir-23b into Skeletal Muscle and Nervous System for the Treatment of DM1

    08:55